Stocks in play: Pure Extracts Technologies Corp.

Announced that its wholly owned subsidiary, Pure Extracts Manufacturing Corp., has received approval from Health Canada to amend its license to permit the sale of cannabis extract products to provincially authorized distributors and retailers nationwide as well as to holders of licenses for the sale of medical cannabis extracts. This approval is the result of an intensive review by Health Canada of Pure Extracts’ internal systems, processes, products and packaging. The Company’s purchase orders from British Columbia, Alberta, Saskatchewan and Ontario are currently being fulfilled by its distribution partner, thus having its own sales licence will allow Pure Extracts’ products to eventually reach all provincial and territorial jurisdictions across Canada without the help of an intermediary. Pure Extracts Technologies Corp. shares C.PULL are trading up 3.90 percent at $0.40.

Read:

• Game On: Top Ways to Trade the Explosive eSports Boom

• Psilocybin May Be the Key to Resolving the Global Obesity Epidemic

• 5 Reasons Why The Next Gold Rush Will Happen In Canada